The best treatment for asthma depends on how severe and frequent your symptoms are, but for most people, the foundation is an inhaled corticosteroid combined with a fast-acting bronchodilator. This combination, used as both a daily controller and a rescue inhaler, reduces severe flare-ups by roughly 60 to 64% compared to using a quick-relief inhaler alone. The days of carrying two separate inhalers and hoping for the best are largely behind us. Modern asthma treatment is built on a stepwise approach: start with what works for mild symptoms and escalate only when needed.
The Combination Inhaler Approach
The biggest shift in asthma treatment over the past decade is something called SMART therapy (Single Maintenance and Reliever Therapy). Instead of taking a daily preventer inhaler and carrying a separate rescue inhaler, you use one combination inhaler for both. It contains a low-dose corticosteroid to reduce airway inflammation plus formoterol, a fast-acting bronchodilator that opens your airways within minutes.
The advantage is simple: every time you reach for relief, you’re also getting a small dose of anti-inflammatory medicine. In pooled clinical data, this approach cut severe exacerbations by 60 to 77% compared to using a short-acting reliever alone. Adolescents in particular saw a 77% reduction. And the total steroid exposure was about 83% lower than what patients on a traditional daily maintenance regimen received, because you only use the inhaler when you actually need it.
For people over 12, the typical maximum is 12 puffs per day. For children aged 5 to 11, the cap is 8 puffs daily. If you’re regularly hitting those limits, that’s a sign your asthma isn’t well controlled and your treatment plan needs reassessing.
Mild Asthma: As-Needed Treatment
If your symptoms are infrequent (a couple of times a month or less), you may not need a daily inhaler at all. Using the combination inhaler only when symptoms arise still provides significant protection against flare-ups. Clinical trials found this as-needed approach reduced severe exacerbations at rates similar to daily maintenance therapy, despite dramatically lower overall medication use.
This is a meaningful change from older guidelines that told nearly everyone with an asthma diagnosis to take a daily preventer. For truly mild, intermittent asthma, reaching for a combination inhaler as needed is now the preferred first step.
How Doctors Gauge Your Response
Not everyone responds equally to inhaled corticosteroids. A simple breath test measuring fractional exhaled nitric oxide (FeNO) can predict how well steroids will work for you. A reading above 50 parts per billion in adults (above 35 in children) strongly suggests you’ll respond well to corticosteroids. Below 25 ppb in adults (below 20 in children), a good response is unlikely, and your doctor may look for a different driver of your symptoms. When the cutoff is set at 47 ppb, the test correctly predicts steroid responsiveness about 80% of the time.
This matters because asthma isn’t one disease. Some people have inflammation driven by allergic pathways that steroids target effectively. Others have airway narrowing from different mechanisms, and piling on more steroids won’t help. The FeNO test takes about two minutes and helps avoid months of trial and error.
When Inhalers Aren’t Enough
If you’re using a combination inhaler at higher doses and still having frequent symptoms or flare-ups, the next tier involves add-on treatments. Your doctor might first try a long-acting muscarinic antagonist, which relaxes the muscles around your airways through a different mechanism than your existing inhaler. Leukotriene modifiers, taken as a daily pill, block another inflammatory pathway and work particularly well for people whose asthma worsens with exercise or allergies.
For people with allergic asthma specifically, allergy immunotherapy can address the root cause rather than just managing symptoms. Sublingual immunotherapy (dissolving tablets or drops under the tongue) has shown lasting benefits: in one large real-world analysis, asthma medication use dropped by nearly 17 percentage points even after treatment ended, compared to people who didn’t receive immunotherapy. This approach requires three to five years of consistent treatment but can produce durable changes in how your immune system reacts to triggers.
Biologic Therapies for Severe Asthma
About 5 to 10% of people with asthma have severe disease that doesn’t respond adequately to standard inhalers. For them, injectable biologic medications can be transformative. These are targeted therapies that block specific molecules driving airway inflammation, and eligibility depends on blood test results that identify which inflammatory pathway is most active.
The main options target different parts of the immune response. Anti-IgE therapy works for allergic asthma, requiring evidence of sensitization to year-round allergens and IgE levels within a specific dosing range based on body weight. Anti-IL5 therapies target a type of white blood cell called eosinophils; you’ll typically qualify if your blood eosinophil count is above 150 to 300 cells per microliter. Anti-IL4 receptor therapy has the broadest eligibility, covering people with elevated eosinophils or high FeNO levels, making it an option for a wider range of severe asthma patients.
These medications are given as injections every two to eight weeks, depending on the specific drug. They’re not first-line treatments because of cost and the need for ongoing injections, but for people who qualify, they can dramatically reduce flare-ups and allow significant reductions in oral steroid use.
Managing Flare-Ups
Even with good baseline control, flare-ups happen. A course of oral corticosteroid tablets is the standard treatment for an acute asthma attack that doesn’t resolve with your inhaler. Adults typically take a five- to seven-day course, while children usually need three to five days. The goal is to rapidly knock down the airway inflammation that’s causing the crisis, then return to your regular maintenance plan.
If you need oral steroids more than once or twice a year, that’s a clear signal your maintenance therapy needs to be stepped up. Frequent steroid courses carry real cumulative risks, including bone thinning, weight gain, and blood sugar disruption, so the priority is always to find a controller regimen that prevents flare-ups in the first place.
Environmental Changes That Move the Needle
Medications work best when you also reduce the triggers that provoke your airways. Among environmental interventions, HEPA air filtration has the strongest evidence, particularly for people exposed to traffic-related pollution or with poorly controlled asthma. In one study of children with poorly controlled asthma, HEPA filtration improved asthma control scores from 1.33 to 0.92, crossing the threshold into well-controlled territory. Forty-five percent of participants with uncontrolled asthma achieved well-controlled status after HEPA treatment, compared to 21% with a placebo filter.
Other practical steps include using allergen-proof mattress and pillow covers if you’re sensitized to dust mites, fixing moisture problems that promote mold growth, and keeping pets out of the bedroom if animal dander is a trigger. None of these replace medication, but they can reduce the amount of medication you need and improve how well it works.
Bronchial Thermoplasty
For adults with severe asthma that remains uncontrolled despite maximum medical therapy, bronchial thermoplasty is a procedure that delivers controlled heat to the airway walls, reducing the excess smooth muscle that causes them to constrict. It requires three separate bronchoscopy sessions, each about three weeks apart.
Five-year follow-up data from the Asthma Intervention Research Trial showed the procedure maintains a stable safety profile, with no deterioration in lung function and no increase in hospitalizations or emergency visits over the tracking period. The rate of respiratory side effects held steady at roughly 1.1 to 1.3 events per patient per year from year two through year five. One patient developed a lung abscess in a treated area 14 months after the procedure, which required surgical treatment. Thermoplasty is a last-resort option, but for the right candidate, it can reduce the frequency and severity of flare-ups when nothing else has worked.